

Product: Methotrexate
Description: CAS: 3475-39-6; anti-tumor ; arthritis; rheumatoid
Category: Anti-Tumor
In-stock: In Stock
Payment Method: T/T, L/C
Shipping Method: AIR, Express
Product Information
CAS No. |
3475-39-6
|
End Use |
Methotrexate
|
M.F. |
C3H3Br3O
|
M.W. | 294.77 |
Assay | 98% |
Shelf Life | 2 Years |
Package | 25kg/drum |
Highlight | CAS: 3475-39-6 Methotrexate Methotrexate 3475-39-6 C3H3Br3O Methotrexate |
Related Products
Additional Information
Application
- 1,2, 3-Tribromoacetone is an impurity of methotrexate (HY-14519). Methotrexate (Amethopterin) is an antimetabolic (antimetabolite) and antifolate (antifolate) agent that inhibits dihydrofolate reductase, thereby preventing the conversion of folate to tetrahydrofolate and inhibiting DNA synthesis.
-
- In vivo study: Methotrexate (Amethopterin) reduces thymus and spleen indices of mice. Methotrexate markedly decreases white blood cells, thymic and splenic lymphocytes at dose ≥5 mg/kg. However, there is a significant difference between the treatment plus control group and the model group (p<0.01). The combination of grape seed proanthocyanidins and Siberian ginseng eleutherosides obviously diminishes the effects of Methotrexate exposure on indices of thymus and spleens in mice. Methotrexate (MTX) (2 mg/kg; i.p.; once in a week for 5 weeks) is effective in Freund's complete adjuvant-induced arthritis. The combination of Methotrexate (1 mg/kg; i.p.; once in a week for 5 weeks) and Curcumin (30 mg/kg and 100 mg/kg, thrice a week for 5 weeks; i.p.) shows a significant anti-arthritic action and protection from hematological toxicity.